(a) A voting board member may not have a contractual relationship with, ownership interest in, or other conflict of interest with:
(1) a pharmaceutical manufacturer or labeler; or
(2) an entity the commission engages to assist in developing preferred drug lists or administering the Medicaid Drug Utilization Review Program.
(b) The executive commissioner may implement this section by:
(1) adopting rules that identify prohibited relationships and conflicts; or
(2) requiring the board to develop a conflict-of-interest policy that applies to the board.

Text of section effective on April 01, 2025